Nanotechnology in Cancer

Nanotechnology in Cancer covers current nanotechnology-based nanotherapeutics involving gold nanoparticles, colloids, gels, magnetic nanoparticles, radiofrequency, gene therapy, biological particles, and the intermolecular interactions associated with nanoparticle based cancer therapy in vivo.

Different cancer types and locations are considered alongside the corresponding treatment types, and the use of imaging technologies and animal models are also explored. Both scientific and clinical aspects are considered by authors coming from both fields, with the authors using their backgrounds from different disciplines to make the connection between cancer and effective drug delivery and therapeutic strategies.

• Authored by leaders from the scientific research and clinical communities who use their background from different disciplines to explore the connections between cancer and effective drug delivery and therapeutic strategies
• Brings together tumor biology, imaging technologies, nanomaterial platforms for drug delivery, therapeutic strategies, and reconstructive surgery
• Explores the clinical and regulatory challenges facing nanomedicine

Dr. Mathur's doctoral training in Biomedical Engineering from Duke University with Master's training in the area of Polymer Chemistry at NC State University provided her an opportunity to develop unique expertise and apply them in the area of reconstructive therapy for cancer patients.

Dr. Mathur's research encompasses a new and upcoming area of Engineered Biologics and their applications in Regenerative Medicine and Nanomedicine.

Her current work at MD Anderson Cancer Center is highly applied and translational for repair and reconstruction of cancer patients. The laboratory that she heads is called Tissue Regeneration and Molecular Cell Engineering Labs (TRAMCEL). The work in the laboratory is focused in many areas of regenerative medicine such as musculofascia, bone, trachea, and microvascular guidance.